Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/7477
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBobokulova Sh.A.-
dc.date.accessioned2023-05-05T07:28:27Z-
dc.date.available2023-05-05T07:28:27Z-
dc.date.issued2023-04-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/7477-
dc.description.abstractBackground. The frequency of registration of acute purulent-destructive lung diseases in patients with SARS-CoV-2 dur ing the pandemic was ambiguous. A study on the features of the clinical, radiological, and microbiological manifestations of purulent-destructive lung diseases in patients with SARS-CoV-2 deserves close attention. Material and methods. The results of a comprehensive examination and treatment of 65 patients with acute purulent-de structive lung diseases who underwent SARS-CoV-2 in 2020 are analyzed. Conclusion. When determining the severity of the condition of patients with acute purulent-destructive lung diseases after suffering SARS-Co V-2, the true picture can be obtained only by applying the criteria of septic complications, because the organ failure and/or dysfunction considered to reflect the true picture of the development of the purulent-inflammatory process.en_US
dc.language.isoenen_US
dc.subjectacute purulent destructive lung diseases, SARS-CoV-2, clinical manifestation, diagnosis, treatmenten_US
dc.titleOn Clinic-Laboratory Features of The Course of Acute Purulent-Destructive Lung Diseases in Patients Undergoing SARS-CoV-2en_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
1. Бобокулова Ш.А.On Clinic-Laboratory Features of The Course of .pdf1.31 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.